Clinically reviewed by Khali Reed, CRNA, APRN
Publisher Brazelia MedSpa & Integrative Wellness
How we sourced this page
Sexual Wellness Boca Raton: What Carries an FDA Approval and What Does Not
Almost nothing written about sexual wellness Boca Raton clinics offer will tell you which of these treatments the FDA has actually approved for the purpose it is being sold for. It is the single most useful thing you could know before spending money, so this page leads with it, service by service, from the federal record.
One category here carries a clear FDA approval for the indication. Estradiol vaginal inserts are approved for the “treatment of moderate to severe dyspareunia (painful sexual intercourse), a symptom of vulvar and vaginal atrophy”, and a generic version was approved on 8 December 2025. Testosterone is likewise approved where levels are genuinely low and documented.
The device and platelet treatments do not hold an FDA clearance for these uses, and the agency has said so directly. That does not make them unavailable or unlawful — a physician may use a legally marketed device outside its labeling as a clinical decision — but it does mean nobody should be selling them to you as approved. Here you will be told which is which before you decide anything.
Treatment status, stated plainly. The energy-based vaginal devices, shockwave therapy and platelet-rich plasma procedures described on this page are not FDA-approved or FDA-cleared for treating sexual function, and no result is claimed or promised for any of them here. They are used outside their cleared indications, which is a clinical decision made with a physician. The hormone treatments described are FDA-approved for the indications stated.
Sexual wellness Boca Raton: the treatments that hold an approval
Start with the part that has a regulatory answer, because it also happens to address the commonest complaint in this category.
Vaginal estrogen. Estradiol vaginal inserts are FDA-approved for the “treatment of moderate to severe dyspareunia (painful sexual intercourse), a symptom of vulvar and vaginal atrophy”. That is not a wellness claim, it is an approved indication for a prescription medicine, and on 8 December 2025 the FDA approved the first generic version of it. Topical vaginal estrogen was also one of the four categories of menopausal hormone therapy covered in the FDA’s February 2026 labeling update, which is set out on the bioidentical hormones page.
This matters because the symptom vaginal estrogen treats — pain, dryness and thinning tissue after menopause — is what sends a great many women looking for a device procedure in the first place. There is an approved medicine for it, it is inexpensive, and a lot of people are never told it exists.
Testosterone, where it is genuinely low. Approved testosterone products treat documented hypogonadism, and low testosterone can affect libido and function. The qualifier is the whole point: it is approved for men whose levels are actually low and confirmed on testing, not as a general enhancement. What the labeling supports and what it does not is set out on the testosterone page.
If either of those fits, it is the place to start, because it is the part of this subject where the evidence and the regulator already agree.
The device treatments, and exactly where they stand
Two device categories get sold heavily in this space, one aimed at vaginal symptoms and one at erectile dysfunction. Neither holds an FDA clearance for the use it is marketed for, and the agency has been explicit about both.
Energy-based vaginal devices. On 24 July 2018 the FDA wrote to a series of aesthetic device manufacturers about exactly this. Its letter regarding two of those lasers states that the agency “have been unable to identify any Food and Drug Administration (FDA) clearance or approval” for them. The marketing claims it identified were for therapeutic use in treating sexual dysfunction, vaginal rejuvenation and urinary stress incontinence. Seven manufacturers received letters the same day.
Shockwave and acoustic wave therapy. Extracorporeal shock wave devices do hold FDA clearances, but read what the classification actually covers. Under 21 CFR 876.5990, an extracorporeal shock wave lithotripter is “a device that focuses ultrasonic shock waves into the body to noninvasively fragment urinary calculi within the kidney or ureter” — kidney stones. Erectile dysfunction is not the cleared indication.
Now the part that is equally true and usually left out. Using a legally marketed device outside its labeling is not research and it is not prohibited: the FDA’s own guidance states that “when a physician uses a legally marketed device outside its labeling to treat a patient and no research is being done, IRB review is not required”. It is a clinical judgement, made with a physician, about whether something is reasonable for you.
So the honest position is narrow and specific. These are offered here. They are used outside their cleared indication. No approval stands behind a promise of results, and you will not be given one.
PRP, and what its clearance actually covers
Platelet-rich plasma procedures for sexual function are marketed under various trade names. The regulatory picture is worth understanding precisely, because it is frequently described as “FDA-cleared” in a way that is technically true and completely misleading.
What is cleared is the equipment that spins your blood. A representative PRP device clearance reads: “designed to be used for the safe and rapid preparation of platelet rich plasma (PRP) from a small sample of blood at the patient’s point of care”, and then narrows further — “the PRP is mixed with autograft or allograft bone prior to application to an orthopedic surgical site to improve bone graft handling characteristics”.
Read that twice. The clearance is for a centrifuge, and the indication attached to it is orthopaedic bone grafting. Injecting the result to treat sexual function sits entirely outside it. A clinic saying the procedure uses an FDA-cleared device is describing the machine, not the treatment.
That is the distinction this page exists to draw. PRP is available here, it is prepared from your own blood, and it is used outside any cleared indication for this purpose. Anyone telling you otherwise is either confused about the paperwork or counting on you being confused about it.
How sexual wellness is handled at Brazelia MedSpa
Sexual wellness here is handled in a deliberate order: what is approved first, what is not approved second, and the reason for choosing either one said out loud.
That means a history and, where relevant, testing before a procedure is discussed. A great deal of what brings people to this subject turns out to be hormonal, and hormonal causes are measurable. Menopausal tissue changes, low testosterone, thyroid, and the metabolic and vascular factors that affect function are all worth establishing first, because several of them have approved treatments and the procedures do not.
Where an approved option fits, you will hear about it first, including when it is the cheaper one. Where you want to consider a device or platelet procedure, you will be told plainly that it is used outside its cleared indication, what is and is not known about it, and what it will cost, before anything is booked.
Anything requiring a physician goes to one; the practice is under the medical direction of Dr. Herbert R. Slavin, MD, on site rather than a name on a licence. Symptoms that point to a vascular, urological or gynaecological problem belong with the relevant specialist, and you will be told that rather than sold a package.
New patients start with a consultation, where all of this is discussed before anything is decided.
Frequently asked questions
Is anything in sexual wellness actually FDA-approved?
Yes. Estradiol vaginal inserts are approved for moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, and the first generic was approved on 8 December 2025. Testosterone is approved where levels are genuinely low and documented. Source 2.
Is vaginal rejuvenation FDA-approved?
No. In July 2018 the FDA wrote to aesthetic device manufacturers stating it had been unable to identify any clearance or approval for lasers marketed for sexual dysfunction, vaginal rejuvenation and urinary stress incontinence. Seven companies received letters on the same day. Source 1.
Is shockwave therapy cleared for erectile dysfunction?
Not for that indication. Extracorporeal shock wave lithotripters are classified under 21 CFR 876.5990 as devices that fragment urinary calculi in the kidney or ureter — kidney stones. Source 3.
Clinics say their PRP device is FDA-cleared. Is that true?
The centrifuge is cleared, for preparing PRP, with the indication narrowed to mixing it with bone graft at an orthopedic surgical site. That says nothing about injecting PRP for sexual function. The claim is about the machine, not the treatment. Source 4.
If these are not approved, is it legal to offer them?
Using a legally marketed device outside its labeling is a clinical decision rather than research. The FDA’s guidance states that when a physician uses a legally marketed device outside its labeling to treat a patient and no research is being done, IRB review is not required. What is not acceptable is selling it to you as approved. Source 5.
Where should I actually start?
With whichever cause is measurable. Hormonal and metabolic contributors are testable and several have approved treatments, so they are worth establishing before a procedure is considered. That is how the consultation here is structured.
What will I be told at the consultation?
Which options hold an approval for your situation and which do not, what each would cost, and what is and is not known about the ones without an approval. Nothing is booked on a first visit unless it is clinically appropriate and you want to proceed.
Sources and how this page was built
The approval status of each treatment on this page is read from primary federal documents on 28 September 2026: an FDA Letter to Industry dated 24 July 2018 for the energy-based devices, the FDA’s December 2025 approval announcement for estradiol vaginal inserts, the device classification at 21 CFR 876.5990 for shock wave devices, a cleared PRP device’s own indications for use, and the FDA’s information sheet on off-label use. Nothing on this page is a diagnosis, and no result is promised for any treatment lacking an approval for the indication.
- FDA. Letter to Industry, InMode MD Ltd., 24 July 2018, regarding the FormaV and FractoraV lasers. fda.gov
- FDA. FDA Approves First Generic Estradiol Vaginal Insert for Treatment of Moderate to Severe Dyspareunia, 8 December 2025. fda.gov
- 21 CFR 876.5990. Extracorporeal shock wave lithotripter, device classification. ecfr.gov
- FDA. 510(k) summary BK241083, platelet rich plasma device indications for use. fda.gov
- FDA. Frequently Asked Questions About Medical Devices, information sheet, on off-label use. fda.gov
Why patients choose Brazelia MedSpa
This page is the best answer we can give. Every practice in South Florida offering these procedures knows which of them carry an FDA approval for the indication, and almost none of them publish it. We have, on the page where we sell them, because a patient who understands what they are buying makes a better decision and is a better patient afterwards. It costs us the easiest claim in the category.
Hormone and metabolic work at Brazelia MedSpa is run by Khali Reed, CRNA, APRN, in a practice under the medical direction of Dr. Herbert R. Slavin, MD, on site rather than a name on a licence.
Brazelia MedSpa has treated patients from the same address in downtown Boca Raton for 18 years, near Mizner Park, and sees patients from across South Florida, from Delray Beach and Boynton Beach to Deerfield Beach and Fort Lauderdale. The programme is run by the same people every visit, which matters more on a medication you take for a year than on a treatment you have once.
Weight is also rarely treated as just weight here. Because Brazelia MedSpa runs hormone, metabolic, skin and regenerative programmes under one roof, thyroid, sleep, training load and the skin changes that follow a large weight reduction can be looked at in the same place, by people who are already talking to each other.
New patients start with a consultation, and nothing is prescribed on a first visit unless it is clinically appropriate and you want to proceed. You will hear what the label supports, what it does not, and what the plan would look like before anything is decided.
This page describes what published labels, regulatory records and peer-reviewed research report about these treatments. It is general health information, not medical advice, and it is not a substitute for a consultation. Whether any treatment is appropriate for you is a clinical judgement that depends on your history and examination.
Talk it through properly, in Boca Raton
New patients start with a consultation, where what is approved, what is not, and what is worth testing first are discussed before anything is decided.